23 / 50
Neumol Pediatr 2015; 10 (3): 111 - 117
C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl
117
La nueva displasia broncopulmonar desde el punto de vista del neumólogo pediatra
19. Rhein L, Simoneau T, Davis J, Correia C, Ferrari D, Monuteaux
M, Gregory M. Reference values of nocturnal oxygenation for
use in outpatient oxygen weaning protocols in premature infants.
Pediatr Pulmonol 2012;47:453-9
20. Brockmann PE, Poets A, Urschitz MS, Sokollik C, Poets CF.
Reference values for pulse oximetry recordings in healthy term
neonates during their first 5 days of life. Arch Dis Child Fetal
Neonatal 2011;96:F335-8
21. Mandy G, Malkar M, Welty S, Brown R, Shepherd E, Gardner
W, Moise A, Gest A. Tracheostomy Placement in Infants With
Bronchopulmonary Dysplasia: Safety and Outcomes Pediatr
Pulmonol 2013;48:245–249
22. Darlow BA, Graham PJ. Vitamin A supplementation to
prevent mortality and short and long-term morbidity in very
low birthweight infants. Cochrane Database Syst Rev 2007 Oct
17;CD000501
23. Nair V, Loganathan P, Soraisham AS. Azithromycin and other
macrolides for prevention of bronchopulmonary dysplasia: a
systematic review and meta-analysis. Neonatol 2014;106:337-47
24. Grier D, Halliday L. Effects of Glucocorticoids on Fetal and
Neonatal Lung Development Treatments. Respir Med 2004, 3:
295-306
25. American Academy of Pediatrics, Canadian Paediatric Society
(fetus and newborn committee). Postnatal corticosteroids to treat
or prevent chronic lung disease in preterm infants. Pediatr 2002;
109: 330-38
26. Onland W, Offringa M, van Kaam A. Late (
≥
7 days) inhalation
corticosteroids to reduce bronchopulmonary dysplasia in preterm
infants. Cochrane Database Syst Rev 2012 Apr 18;4:CD002311
27. Segar JL. Neonatal diuretic therapy: furosemide, thiazides,
and spironolactone. Clin Perinatol. 2012; 39:209-20
28. Greenough A. Long term respiratory outcomes of very
premature birth (<32 weeks). Semin Fetal Neonatal Med
2012;17:73-6
29. Updated Guidance for Palivizumab Prophylaxis Among Infants
and Young Children at Increased Risk of Hospitalization for
Respiratory Syncytial Virus Infection. Pediatr 2014, 134: 415-42
30. Hudak B, Allen M, Hudak M, Loughlin G. Home Oxygen
Therapy for Chronic Lung Disease in Extremely Low-Birth-Weight
Infants. Am J Dis Child 1989; 143: 357- 360
31. Hennessy E, Bracewell M, Wood N, Wolke D, Costeloe K,
Gibson A, Marlow N for the EPICure Study Group. Respiratory
health in pre-school and school age children following extremely
preterm birth. Arch Dis Child 2008;93:1037–1043
32. Palm K, Simoneau T, Sawicki G, Rhein L. Assessment
of Current Strategies for Weaning Premature Infants From
Supplemental Oxygen in the Outpatient Setting. Adv Neonatal
Care 2011; 11:349-356
33. Cristea A, Carroll A, Davis S, Swigonski N, Ackerman V.
Outcomes of Children With Severe Bronchopulmonary Dysplasia
Who Were Ventilator Dependent at Home. Pediatr 2013; 132:
727-734
34. Fawke J, Lum S, Kirkby J, Hennessy E, Marlow N, Rowell
V, Thomas S, and J. Stocks J. Lung Function and Respiratory
Symptoms at 11 Years in Children Born Extremely Preterm The
EPICure Study. Am J Respir Crit Care Med 2010;182: 237–245
35. Carraro S, Filippone M, Da Dalt L, Ferraro V, Maretti M, Bressan
S, El Mazloum D, Baraldi E. Bronchopulmonary dysplasia: the
earliest and perhaps the longest lasting obstructive lung disease
in humans. Early Hum De 2013; 89 Suppl 3:S3-5